Emerging country markets are widely viewed as Big Pharma’s ace in the hole to replace declining rates of innovation in the US and Europe, with numerous studies claiming the BRICK nations (the ‘K’ is from South Korea) are at the center of a revolutionary global shift in the source points for new ideas — what [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Emerging Countries' R&D: A Contest, but No Wipe Out